Transcatheter aortic valve implantation in patients with significant septal hypertrophy.

ABSTRACT:

Background

Previous reports suggest septal hypertrophy with an interventricular septum depth (IVSD) ≥ 14 mm may adversely affect outcomes after transcatheter aortic valve implantation (TAVI) due to suboptimal valve placement, valve migration, or residual increased LVOT pressure gradients.

Aims

This analysis investigates the impact of interventricular septal hypertrophy on acute outcomes after TAVI.

Methods

Between 2009 and 2021, 1033 consecutive patients (55.8% male, 80.5 ± 6.7 years, EuroSCORE II 6.3 ± 6.5%) with documented IVSD underwent TAVI at our center and were included for analysis. Baseline, periprocedural, and 30-day outcome parameters of patients with normal IVSD (< 14 mm; group 1) and increased IVSD (≥ 14 mm; group 2) were compared. Data were retrospectivel

SUBMITTER: Beyer M 

PROVIDER: S-EPMC11914327 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature